The Scientific Team at Ncardia specializes in advancing drug discovery by leveraging human iPSC technology. This team is responsible for differentiating, manufacturing, and characterizing high-quality iPSC-derived cells and disease models. They facilitate disease modeling and high-throughput screening processes and collaborate closely with biopharmaceutical clients to develop customized iPSC-based solutions that meet specific research and development needs.
View all